A 3D Bioprinted Pseudo-Bone Drug Delivery Scaffold for Bone Tissue Engineering.
Source check: Needs source check. Not independent scientific confirmation.
Finding: ANN-supported optimization selected a 3D-printed simvastatin scaffold with 20-day in-vitro release. The primary abstract reports hardness and resilience near healthy bone in a mechanically fractured human clavicle model. These release and ex-vivo mechanical endpoints do not establish living-organism healing or clinical benefit.
Technology: Artificial neural network for scaffold optimization
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- A multilayer feed-forward/back-propagation artificial neural network optimized scaffold formulation using thermogelation and drug-release responses; it did not test biological healing.
- Test and result
- Thirty-nine scaffold formulations were evaluated with ANN-supported optimization. The selected 14% PPF/16% PF127 formulation released simvastatin in vitro for 20 days. The abstract reports hardness and resilience near healthy bone in a mechanically fractured human clavicle model; specimen and replicate counts were not assessed in this review.
- Limitation / still unknown
- Living-organism bone healing and patient benefit are not established by the reported in-vitro release and ex-vivo mechanical model. Specimen and replicate counts were not assessed.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.3390/pharmaceutics12020166
Needs source check · editorial details
The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 18 Nov 2026. Review scope: Publisher abstract and indexed publisher Methods/Results passages on ANN/formulations and drug release; complete article and mechanical-model methods not independently reviewed..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.